These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31690574)

  • 1. Benefits and harms of intensive glycemic control in patients with type 2 diabetes.
    Rodriguez-Gutierrez R; Gonzalez-Gonzalez JG; Zuñiga-Hernandez JA; McCoy RG
    BMJ; 2019 Nov; 367():l5887. PubMed ID: 31690574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.
    Lipska KJ; Krumholz H; Soones T; Lee SJ
    JAMA; 2016 Mar; 315(10):1034-45. PubMed ID: 26954412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.
    Rodríguez-Gutiérrez R; Montori VM
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):504-12. PubMed ID: 27553599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of timely basal insulin control in patients with type 2 diabetes.
    Lovre D; Fonseca V
    J Diabetes Complications; 2015 Mar; 29(2):295-301. PubMed ID: 25536866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypoglycemia in older adults with type 2 diabetes.
    Freeman J
    Postgrad Med; 2019 May; 131(4):241-250. PubMed ID: 30724638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Centered Guidelines for Geriatric Diabetes Care: Potential Missed Opportunities to Avoid Harm.
    McCreedy EM; Kane RL; Gollust SE; Shippee ND; Clark KD
    J Am Board Fam Med; 2018; 31(2):192-200. PubMed ID: 29535235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.
    Shogbon AO; Levy SB
    Am J Health Syst Pharm; 2010 May; 67(10):798-805. PubMed ID: 20479101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycemic targets and cardiovascular morbi-mortality].
    Bordier L; Bauduceau B
    Presse Med; 2013 May; 42(5):855-60. PubMed ID: 23286961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive insulin therapy in hospitalized patients: a systematic review.
    Kansagara D; Fu R; Freeman M; Wolf F; Helfand M
    Ann Intern Med; 2011 Feb; 154(4):268-82. PubMed ID: 21320942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypoglycemia and cardiovascular risk].
    Avogaro A
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2011 Jun; (6):CD008143. PubMed ID: 21678374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic management in diabetes and the associated cardiovascular risk: are we helping or hurting our patients?
    Koshizaka M; Green JB; Alexander JH
    Circ J; 2012; 76(7):1572-80. PubMed ID: 22789974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
    Ma J; Yang W; Fang N; Zhu W; Wei M
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline.
    Slinin Y; Ishani A; Rector T; Fitzgerald P; MacDonald R; Tacklind J; Rutks I; Wilt TJ
    Am J Kidney Dis; 2012 Nov; 60(5):747-69. PubMed ID: 22999165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Sardar P; Udell JA; Chatterjee S; Bansilal S; Mukherjee D; Farkouh ME
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25944874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of hypoglycemia in patients with Type 2 diabetes.
    Liu S; Zhao Y; Hempe JM; Fonseca V; Shi L
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):47-51. PubMed ID: 22280196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.
    Yun JS; Ko SH
    Korean J Intern Med; 2015 Jan; 30(1):6-16. PubMed ID: 25589828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.